MedPath

Evaluation of the role of unattended sleep monitoring in the management of patients with sleep apnoea being treated with an oral appliance.

Not Applicable
Conditions
Obstructive sleep apnoea
Respiratory - Sleep apnoea
Registration Number
ACTRN12609000533291
Lead Sponsor
Institute for Breathing and Sleep
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

Mild to moderate obstructive sleep apnoea (OSA) referred for oral appliance treatment

Exclusion Criteria

Poor oral hygiene
Inadequate dentition
Unable to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Apnoea Hypopnoea Index will be the primary outcome. This outcome will be measured by a full in-laboratory overnight polysomnogram.[For participants in the control arm this endpoint will be measured 1 month after participants are comfortable with using the oral appliance on a nightly basis. For participants in the intervention arm, it will be measured 1 month after advancement is considered to be optimal.]
Secondary Outcome Measures
NameTimeMethod
Quality of Life - measured by Functional Outcomes of sleep questionnaire and the sf36 questionnaire<br>Symptoms - measured by the Sleep Apnoea Symptom Questionnaire<br>Subjective Sleepiness - measured by the Epworth Sleepiness Scale[For participants in the control arm this endpoint will be measured 1 month after participants are comfortable with using the oral appliance on a nightly basis. For participants in the intervention arm, it will be measured 1 month after advancement is considered to be optimal.]
© Copyright 2025. All Rights Reserved by MedPath